Dark Forest Capital Management LP Insmed Inc Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $271,680 - $316,256	10,563 New	10,563 $286,000
Q3 2023 Nov 13, 2023	BUY	$19.86 - $26.93 $174,291 - $236,337	8,776 Added 13.64%	73,129 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $824,646 - $1.06 Million	50,161 Added 353.45%	64,353 $1.36 Million
Q1 2023 May 12, 2023	BUY	$16.26 - $21.73 $230,761 - $308,392	14,192 New	14,192 $241,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $87,696 - $118,482	4,200 New	4,200 $90,000
Q1 2022 May 13, 2022	SELL	$20.42 - $28.13 $4,124 - $5,682	-202 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$25.89 - $33.45 $5,229 - $6,756	202 New	202 $6,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.